AU2003259835A1 - Antibodies that immunospecifically bind to trail receptors - Google Patents

Antibodies that immunospecifically bind to trail receptors

Info

Publication number
AU2003259835A1
AU2003259835A1 AU2003259835A AU2003259835A AU2003259835A1 AU 2003259835 A1 AU2003259835 A1 AU 2003259835A1 AU 2003259835 A AU2003259835 A AU 2003259835A AU 2003259835 A AU2003259835 A AU 2003259835A AU 2003259835 A1 AU2003259835 A1 AU 2003259835A1
Authority
AU
Australia
Prior art keywords
antibodies
immunospecifically bind
trail receptors
trail
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003259835A
Other languages
English (en)
Other versions
AU2003259835A8 (en
Inventor
Vivian A. Albert
Craig A. Rosen
Steven M. Ruben
Theodora Salcedo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2003259835A8 publication Critical patent/AU2003259835A8/xx
Publication of AU2003259835A1 publication Critical patent/AU2003259835A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003259835A 2002-08-15 2003-08-15 Antibodies that immunospecifically bind to trail receptors Abandoned AU2003259835A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US40338202P 2002-08-15 2002-08-15
US60/403,382 2002-08-15
US42573002P 2002-11-13 2002-11-13
US60/425,730 2002-11-13
US46805003P 2003-05-06 2003-05-06
US60/468,050 2003-05-06
PCT/US2003/025457 WO2004016753A2 (fr) 2002-08-15 2003-08-15 Anticorps se fixant de facon immunospecifique a des recepteurs trail

Publications (2)

Publication Number Publication Date
AU2003259835A8 AU2003259835A8 (en) 2004-03-03
AU2003259835A1 true AU2003259835A1 (en) 2004-03-03

Family

ID=31892094

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003259835A Abandoned AU2003259835A1 (en) 2002-08-15 2003-08-15 Antibodies that immunospecifically bind to trail receptors

Country Status (4)

Country Link
EP (1) EP1534336A4 (fr)
AU (1) AU2003259835A1 (fr)
CA (1) CA2494372C (fr)
WO (1) WO2004016753A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288439B2 (en) * 2003-11-04 2012-10-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for the inhibition of HIV-1 replication
CN101031319A (zh) * 2003-12-11 2007-09-05 舍林股份公司 改善放射性标记药物的功效的放射增敏剂缀合物
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
PE20090499A1 (es) 2007-08-09 2009-05-18 Boehringer Ingelheim Int Anticuerpos anti-cd37
KR20110009095A (ko) 2008-03-03 2011-01-27 더 유니버시티 오브 마이애미 동종 이계 암 세포-기반 면역 요법
JP2015517511A (ja) * 2012-05-16 2015-06-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｄ３７抗体とｉｃｅ（イフォスファミド、カルボプラチン、エトポシド）の併用
ES2812208T3 (es) 2013-03-14 2021-03-16 Bristol Myers Squibb Co Combinación de un agonista de DR5 y un antagonista de anti-PD-1 y métodos de uso
US20180028521A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Methods of Treating Prostate Cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500877A (ja) * 1998-01-26 2002-01-15 ジェネンテク・インコーポレイテッド 細胞死レセプター４（ｄｒ４）に対する抗体及びその使用
DK1303293T3 (da) * 2000-07-27 2009-03-30 Genentech Inc Sekventiel indgivelse af CPT-11 og APO-2L-polypeptid
NZ529359A (en) * 2001-05-25 2007-04-27 Human Genome Sciences Inc Antibodies that immunospecifically bind to a TR4 polypeptide or polypeptide fragment or variant of TR4 and their use in a medicament for treating cancer

Also Published As

Publication number Publication date
EP1534336A2 (fr) 2005-06-01
WO2004016753A2 (fr) 2004-02-26
WO2004016753A3 (fr) 2004-06-17
EP1534336A4 (fr) 2005-12-14
AU2003259835A8 (en) 2004-03-03
CA2494372A1 (fr) 2004-02-26
CA2494372C (fr) 2013-05-28

Similar Documents

Publication Publication Date Title
EP1572874A3 (fr) Anticorps se liant de maniere immunospecifique a des recepteurs de trail
EP1465925A4 (fr) Anticorps se liant de maniere immunospecifique a des recepteurs trail
HK1075470A1 (en) Antibodies that immunospecifically bind to trail receptors
AU2002364954A1 (en) ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS
TWI366570B (en) Antibodies to madcam
EP1535930A4 (fr) Anticorps specifique a une proteine-tetra centrale
AU2003295411A1 (en) Human monoclonal antibodies to heparanase
NO20033074D0 (no) Antistoffer mot reseptoren for insulin-lignende vekstfaktor I
HK1178921A1 (en) Antibodies to m-csf m-csf
AU2003218456A1 (en) Antibodies that specifically bind to gmad
AU2003234706A1 (en) Antibodies that specifically bind to tl5
AU2003240822A1 (en) Antibodies that specifically bind to neurokinin b
EP1633316A4 (fr) Anticorps se liant de maniere immunospecifique aux recepteurs trail
AU2003256299A1 (en) Antibodies that specifically bind to reg iv
IL181576A0 (en) 2,4,6-TRIAMINO -S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE
AU2003259835A1 (en) Antibodies that immunospecifically bind to trail receptors
AU2002352676A1 (en) Antibodies that immunospecifically bind to trail receptors
AU2001297702A1 (en) Antibodies that immunospecifically bind to trail receptors
AU2002368062A1 (en) Bispecific antibodies that bind to vegf receptors
AU2003228483A1 (en) Antibodies that specifically bind to tr2
AU2002953290A0 (en) Monoclonal antibodies to cyclospora
AU2002345927A1 (en) Bispecific antibodies that bind to vegf receptors
AU2004901994A0 (en) Antibodies to insulin-like growth factor I receptor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase